Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 58.65
+2.95 (5.30%)
Sep 30, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 30.37 billion as of September 29, 2026. Its market cap has decreased by -21.90% in one year.
Market Cap
30.37B
Enterprise Value
33.83B
Revenue
8.58B
Ranking
n/a
PE Ratio
30.54
Stock Price
58.65
ChartMarket Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 30.37B, an increase of 13.92%. That is a compound annual growth rate of 1.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 30.37B | -2.05% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 62.48B |
| Biocytogen Pharmaceuticals (Beijing) | 57.42B |
| 3SBio | 38.93B |
| Shanghai Junshi Biosciences | 35.83B |
| InSilico Medicine Cayman TopCo | 30.98B |
| InnoCare Pharma | 29.27B |
| Zai Lab | 22.00B |
| Keymed Biosciences | 21.55B |